XOMA Corp XOMA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
24.78quote price arrow down-0.66 (-2.59%)
Volume
7,744
52 week range
13.48 - 27.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.78
  • 52 Week High27.00
  • 52 Week High Date04/03/24
  • 52 Week Low13.48
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap288.316M
  • Shares Out11.64M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change33.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.78
  • 52 Week High27.00
  • 52 Week High Date04/03/24
  • 52 Week Low13.48
  • 52 Week Low Date10/04/23
  • Market Cap288.316M
  • Shares Out11.64M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change33.95

RATIOS/PROFITABILITY

  • EPS (TTM)-4.04
  • P/E (TTM)-6.13
  • Fwd P/E (NTM)-9.21
  • EBITDA (TTM)-25.12M
  • ROE (TTM)-27.24%
  • Revenue (TTM)4.758M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-858.15%
  • Debt To Equity (MRQ)139.83%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On XOMA Corp

 

Profile

MORE
XOMA Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. Its royalty portfolio includes DAY101...
Jack Wyszomierski
Independent Chairman of the Board
Owen Hughes Jr.
Chief Executive Officer, Director
Thomas Burns
Chief Financial Officer, Senior Vice President - Finance
Address
Suite 310, 2200 Powell Street
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
VRCA
Verrica Pharmaceuticals Inc
7.26+0.50+7.40%
VSTM
Verastem Inc
10.90+0.54+5.21%
LYRA
Lyra Therapeutics Inc
4.03-0.60-12.96%
AVXL
Anavex Life Sciences Corp
3.85+0.09+2.39%
OPT
Opthea Ltd
3.42+0.10+2.95%